Subtype
Intermediate Fibroblastic Neoplasm
CI-CAN-00001015Explore in graph →
Non-malignant31 active trials31 evidence items
- NCIt
- C7333
Loading cancer entity…
Subtype
CI-CAN-00001015Explore in graph →
Clinical trials
128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05561036 | A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor | unknown | Phase 3 | 72 | Sun Yat-sen UniversityOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT03874273 | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors | unknown | Phase 2 / Phase 3 | 25 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Mar 14, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Sep 30, 2022source: clinicaltrials